Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes

FEMS Microbiology Letters
Judy HigginsTimothy Foster

Abstract

Staphylococcus aureus is a major cause of nosocomial and community-acquired infection. It expresses several factors that promote avoidance of phagocytosis by polymorphonuclear leucocytes. Clumping factor A (ClfA) is a fibrinogen-binding surface protein of S. aureus that is an important virulence factor in several infection models. This study investigated whether ClfA is an antiphagocytic factor, and whether its antiphagocytic properties were based on its ability to bind fibrinogen. In S. aureus, ClfA was shown to be of equal importance to protein A, the antiphagocytic properties of which are well established. ClfA expressed in a surrogate Gram-positive host was also found to be antiphagocytic. A ClfA mutant that was unable to bind fibrinogen had a similar antiphagocytic effect to native ClfA in the absence of fibrinogen. ClfA inhibited phagocytosis in the absence of fibrinogen, and showed enhanced inhibition in the presence of fibrinogen.

References

Jun 1, 1993·The Journal of Applied Bacteriology·J M WellsR W Le Page
Oct 1, 1996·Applied and Environmental Microbiology·P G de RuyterW M de Vos
Apr 18, 1998·The Journal of Biological Chemistry·D P O'ConnellT J Foster
May 4, 2001·Journal of Immunological Methods·M SuS J Mentzer
Jun 18, 2002·Infection and Immunity·Thanh T Luong, Chia Y Lee
Sep 14, 2002·Infection and Immunity·Ruth C MasseySharon J Peacock
Dec 11, 2002·Microbial Pathogenesis·Niklas PalmqvistElisabet Josefsson
Feb 1, 1952·Journal of General Microbiology·E S DUTHIE, L L LORENZ
Mar 9, 2005·Clinical and Diagnostic Laboratory Immunology·Agnieszka DrylaEszter Nagy
Oct 26, 2005·Trends in Microbiology·Suzan H M RooijakkersJos A G van Strijp
Dec 3, 2005·Nature Reviews. Microbiology·Timothy J Foster

❮ Previous
Next ❯

Citations

Nov 1, 2011·Seminars in Immunopathology·Dane Parker, Alice Prince
Jan 28, 2012·Seminars in Immunopathology·Ian A Myles, Sandip K Datta
Feb 13, 2008·The Journal of Experimental Medicine·Frank R DeLeo, Michael Otto
Oct 8, 2009·The Journal of Experimental Medicine·Vilasack ThammavongsaOlaf Schneewind
Jun 12, 2008·The Journal of Infectious Diseases·Pamela S HairKenji M Cunnion
Jun 29, 2011·Infection and Immunity·Emma Jane SmithTimothy J Foster
Jun 3, 2010·BMC Microbiology·Fiona M BurkeTimothy J Foster
Nov 16, 2011·Future Microbiology·Lucio MontanaroCarla Renata Arciola
Mar 1, 2011·Trends in Microbiology·Alice G ChengDominique Missiakas
Jul 4, 2007·The Journal of Allergy and Clinical Immunology·Victor Nizet
Jul 17, 2009·Clinical and Experimental Immunology·S AnwarI Sabroe
Mar 22, 2016·Pathogens·Will A McGuinnessFrank R DeLeo
Oct 11, 2017·Journal of Food Protection·Reuven RasoolyBradley J Hernlem
Mar 27, 2019·Autophagy·Padhmanand SudhakarIoannis P Nezis
Nov 14, 2019·Current Osteoporosis Reports·Gowrishankar MuthukrishnanEdward M Schwarz
May 29, 2020·Antioxidants & Redox Signaling·Viktoria Rungelrath, Frank R DeLeo
Nov 26, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Florian H PilsczekPaul Kubes
Oct 16, 2012·The International Journal of Artificial Organs·Stefano RavaioliCarla Renata Arciola
Nov 20, 2015·Physiological Reviews·Dane ParkerAlice Prince

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.